Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Mizuho: Sanae Takaichi May Need More Cautious Market Communication

Mizuho: Sanae Takaichi May Need More Cautious Market Communication

金十金十2026/07/10 02:32
Show original
```htmlGolden Ten Data reported on July 10 that Mizuho Securities economist Yusuke Matsuo stated that Japanese Prime Minister Sanae Takaichi may need to adopt a more cautious and market-oriented approach when communicating on highly sensitive issues. Matsuo noted that these topics include the funding source for the planned food consumption tax reduction and her large-scale investment plan. Japanese government bond yields have recently surged as the market fears that political pressure could delay the Bank of Japan's interest rate hike and intensify inflation risks. Japanese Finance Minister Kazuki Katayama emphasized the central bank's independence on Friday, saying that specific monetary policy measures are determined by the Bank of Japan.```
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD

Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.

智通财经2026/09/21 07:16

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11

Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential

According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.

智通财经2026/09/21 07:11

Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.

TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).

智通财经2026/09/21 07:11